68.7%, respectively; P = 0.017), but was higher compared with those who received DTG/3TC, although this difference did not reach statistical significance (64.6% vs. 59.9%, respectively; P = 0.080; Table 2 ).
← all excerpts
Real-World Persistence in Adults with HIV and Mental Health or Substance Use Disorders After Restarting Antiretroviral Therapy in the United States.
1
0.0800
0.0800